Company: CRVO
Filing Date: 2025-01-31
Form Type: 8-K
Source: 0001437749-25-002329
Chunk: 0

Company: CervoMed Inc.
Filing Date: 2025-01-31
Form: 8-K
Item: Item 7.01
Chunk 0
---

Item 7.01   Regulation FD Disclosure
------------------------------------
Press Release
 
On January 31, 2025, CervoMed Inc. (the “Company”) issued a press release providing an update on its neflamapimod development program in dementia with Lewy bodies in connection with the Company’s oral presentation at the 8th International Lewy Body Dementia Conference (ILDBC). A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
 
Presentation
 
Certain information concerning the business, clinical studies, development plans, financial position and related matters of the Company is being made available on its website, www.cervomed.com, under the heading, “Investors – Events and Presentations” and a copy of which is attached as Exhibit 99.2 hereto. Representatives of the Company may use this presentation, in whole or in part, and possibly with non-material modifications, periodically in connection with conferences, meetings, and presentations to investors, analysts and others, including a presentation of the information contained therein at the ILDBC on January 31, 2025.
 
The information contained in the presentation is summary information that is intended to be considered in the context of the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”) and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in the presentation except as required by applicable law, although the Company may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases, or through other public disclosure. The Company makes no admission or representation as to the materiality of any information in the presentation or otherwise contained in Item 7.01 of this Current Report on Form 8-K.
 
The information in this Item 7.01 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.